Summary

Equine Artificial Insemination Market Summary

The global equine artificial insemination market size was estimated at USD 648.17 million in 2024 and is projected to reach USD 1,077.33 million by 2033, growing at a CAGR of 5.94% from 2025 to 2033. The market is advancing, driven by rising demand for high-value breeding and genetic improvement, advancements in reproductive technologies and veterinary expertise, anddisease control and biosecurity benefits.

The growing demand for high-performance horses in sports, racing, and leisure activities is a major market growth driver. Artificial insemination enables breeders to access superior stallion genetics without geographical limitations, improving offspring quality and market value. In 2022, 1,248 stallions bred 28,548 mares in North America, producing 18,143 live foals for 2023, according to the Jockey Club’s Live Foal Report released in October 2023.

Artificial insemination also reduces the risks associated with live cover, such as injuries or disease transmission. Along with technological advancements in semen freezing, storage, and shipping, breeders can utilize genetic material globally, expanding breeding options. This ability to selectively improve desirable traits in foals is fueling artificial insemination adoption among professional breeders and equestrian organizations worldwide.

Technological improvements in semen collection, cryopreservation, and reproductive hormone management have significantly enhanced the success rates of equine artificial insemination. The availability of skilled veterinary professionals and specialized reproduction centers has made artificial insemination more accessible and efficient for breeders. Techniques such as deep-horn insemination and ultrasound-guided procedures improve conception rates, even in mares with challenging reproductive histories. Furthermore, artificial insemination supports better scheduling and planning of breeding programs, allowing multiple mares to be serviced from a single stallion. These innovations are reducing costs, increasing efficiency, and boosting the commercial appeal of artificial insemination in the equine breeding industry. The chart below illustrates a detailed description of various technologies used for artificial insemination:

Equine artificial insemination offers substantial biosecurity advantages, making it a preferred choice for breeders concerned about disease prevention. By eliminating the need for physical contact between stallions and mares, artificial insemination minimizes the risk of transmitting sexually transmitted infections and other contagious equine diseases. Processed semen can also be screened and treated before use, ensuring better herd health. This is especially critical for high-value breeding programs, where disease outbreaks could cause significant financial and genetic losses. As awareness of animal health and welfare grows, artificial insemination as a safe and controlled breeding method continues to strengthen its market demand.

Global Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine artificial insemination market report based on solution, equine, distribution channel, and region:

• Solution Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment & Consumables
• Semen
o Normal Semen
o Sexed Semen
• Services
• Equine Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/Racing
• Recreation
• Other Type
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Private
• Public
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o India
o China
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
o Qatar
o Oman

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Equine Artificial Insemination Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Equine Artificial Insemination Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Estimated Equine Population by key countries, 2024
Chapter 4. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Equine Artificial Insemination Market: Solution Movement Analysis
4.3. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
4.4. Equipment & Consumables
4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Semen
4.5.1. Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Normal Semen
4.5.2.1. Normal Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Sexed Semen
4.5.3.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Services
4.6.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Equine Artificial Insemination Market: Equine Movement Analysis
5.3. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
5.4. Sports/Racing
5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Recreation
5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Equine Artificial Insemination Market: By Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Equine Artificial Insemination Market: By Distribution Channel Movement Analysis
6.3. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.3.1. Private
6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Public
6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Equine Artificial Insemination Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Equine Artificial Insemination Market Share, By Region, 2024 & 2033 (USD Million)
7.3. Regional Outlook
7.4. North America
7.4.1. North America Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. U.S. Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Canada Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Mexico Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
7.5.1. Europe Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. UK Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Germany Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. France Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Italy Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Spain Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Denmark Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Sweden Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Norway Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Japan Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. China Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. India Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Australia Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. South Korea Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Thailand Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Brazil Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Argentina Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. South Africa Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Saudi Arabia Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. UAE Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.6. Qatar
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.8.7. Oman
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Kuwait Equine Artificial Insemination Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. IMV Technologies
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product/ Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Stallion AI Services
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product/ Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Zoetis
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product/ Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. NEOGEN Corporation
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product/ Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Zerlotti Genetics Ltd
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product/ Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. ERC s.r.o.
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product/ Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. CVS (UK) Limited.
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product/ Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. HOFFMAN A.I. BREEDERS INC.
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product/ Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Nasco
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product/ Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Continental Genetics, LLC
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product/ Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. MINITÜB GMBH
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product/ Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Sussex Equine Hospital
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product/ Service Benchmarking
8.3.12.4. Strategic Initiatives